Related Experiment Video
Updated: Jun 5, 2026
10:18
In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium
Published on: May 6, 2018
Control of clot lysis by gene transfer
S W Lee1, M L Kahn, D A Dichek
1Molecular Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, MD 20892, USA.
Trends in Cardiovascular Medicine
|January 20, 2011
Summary
Gene transfer can enhance the body's clot-dissolving ability by increasing plasminogen activators in blood vessel cells. This approach holds promise for treating intravascular clot formation and preventing serious complications.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Cardiovascular Research
Background:
- Intravascular clot formation poses significant clinical risks, including limb loss and mortality.
- Enhancing local fibrinolytic activity is crucial for managing thrombosis.
- Gene transfer presents a novel strategy for modulating vascular function.
Purpose of the Study:
- To investigate the potential of gene transfer for enhancing local fibrinolytic activity.
- To explore the use of recombinant plasminogen activators for clot dissolution.
- To assess the feasibility of gene therapy in the context of vascular thrombosis.
Main Methods:
- Gene transfer of plasminogen activators into endothelial cells.
- In vitro assessment of endothelial cell fibrinolytic activity.
- Evaluation of secreted and cell surface-anchored plasminogen activators.
Main Results:
- Gene transfer successfully increased endothelial cell fibrinolytic activity in vitro.
- Both secreted and cell surface-anchored plasminogen activators demonstrated efficacy.
- Demonstrated proof-of-concept for gene-mediated enhancement of fibrinolysis.
Conclusions:
- Gene transfer is a viable strategy to boost local fibrinolysis.
- Targeting endothelial cells with plasminogen activator genes shows therapeutic potential.
- Further in vivo studies are warranted to confirm clot lysis efficacy.
More Related Videos
Related Concept Videos
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
02:53Conservative Site-specific Recombination and Phase Variation
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...